英文同义词:
OSS-128167;OSS 128167;OSS128167;OSS-128167(SIRT6-IN-1);OSS-128167;SIRT6-IN-1;Benzoic acid, 5-[[3-[(2-furanylcarbonyl)amino]benzoyl]amino]-2-hydroxy-
生物活性
OSS_128167 (SIRT6-IN-1)是一种特异性的 SIRT6 抑制剂,对SIRT6, SIRT1和SIRT2的IC50分别为89, 1578和751 μM。OSS_128167 在HBV的转录和复制中起到抗病毒的作用。
靶点
Target Value
SIRT6
(Cell-free) 89 μM
SIRT2
(Cell-free) 751 μM
SIRT1
(Cell-free) 1578 μM
体外研究
OSS-128167对SIRT6具有特异性,其对SIRT1和SIRT2的IC50s比对SIRT6的高约20倍。它具有细胞渗透性,在培养细胞中具有活性。OSS-128167能够增加H3K9乙酰化和GLUT-1的表达水平。
体内研究
OSS_128167 (50 mg/kg; intraperitoneal injection; every 4 days; for 12 days; male HBV transgenic mice) treatment markedly suppresses the level of HBV DNA and 3.5-Kb RNA in HBV transgenic mice.
Animal Model: Male HBV transgenic mice (6-8-week-old)
Dosage: 50 mg/kg
Administration: Intraperitoneal injection; every 4 days; for 12 days
Result: The level of HBV DNA and 3.5-Kb RNA were markedly suppressed in HBV transgenic mice.
Animal Model:
Male HBV transgenic mice (6-8-week-old)
Administration:
Intraperitoneal injection; every 4 days; for 12 days
Result:
The level of HBV DNA and 3.5-Kb RNA were markedly suppressed in HBV transgenic mice.